The 10/66 Dementia Research Group's fully operationalised DSM-IV dementia computerized diagnostic algorithm, compared with the 10/66 dementia algorithm and a clinician diagnosis: a population validation study by Prince, Martin J et al.
BioMed  Central
Page 1 of 12
(page number not for citation purposes)
BMC Public Health
Open Access Research article
The 10/66 Dementia Research Group's fully operationalised 
DSM-IV dementia computerized diagnostic algorithm, compared 
with the 10/66 dementia algorithm and a clinician diagnosis: a 
population validation study
Martin J Prince*1, Juan Llibre de Rodriguez2, L Noriega3, A Lopez4, 
Daisy Acosta5, Emiliano Albanese1, Raul Arizaga6, John RM Copeland7, 
Michael Dewey1, Cleusa P Ferri1, Mariella Guerra8, Yueqin Huang9, 
KS Jacob10, ES Krishnamoorthy11, Paul McKeigue12, Renata Sousa13, 
Robert J Stewart14, Aquiles Salas15, Ana Luisa Sosa, Richard Uwakwa for the 
10/66 Dementia research group
Address: 1Section of Epidemiology, Health Services Research, King's College London, De Crespigny Park, London SE5 8AF, UK, 2Facultad de 
Medicina Finley-Albarran, Medical University of Havana, Cuba, 3University Policlinic "19 de Abril", Havana, Cuba, 4Community Mental Health 
Centre, Marianao, Havana, Cuba, 5Universidad Nacional Pedro Henriquez Ureña (UNPHU), John F Kennedy Avenue, Internal Medicine 
Department, Geriatric Section, Santo Domingo, Dominican Republic, 6Behavioral and Cognitive Neurology Unit, Neuraxis Institute – 
Neurological Foundation, Buenos Aires, Argentina, 7University of Liverpool, 6 Stanley Road, Hoylake Wirral, CH47 1HW, UK, 8Psychogeriatric 
Unit, National Institute of Mental Health "Honorio Delgado Hideyo Noguchi", José Galvez Barrenechea Avenue # 274. Department 401. Corpac 
-SAN ISIDRO Lima, Perú, 9Peking University, Institute of Mental Health. # 51 Hua Yuan Bei Road Haidian District Beijing, 100083, PR China, 
10Christian Medical College, Vellore, India, 11Srinivasan Centre for Clinical Neurosciences. The Institute of Neurological Sciences, Voluntary 
Health Services, Taramani, Chennai, India, 12Public Health Sciences/Molecular Medicine Centre, MRC Human Genetics Unit, University of 
Edinburgh, UK, 13Medicine Department, Caracas University Hospital, Faculty of Medicine, Universidad Central de Venezuela, Caracas, Venezuela, 
14The Cognition and Behavior Unit, National Institute of Neurology and Neurosurgery of Mexico, Av. Insurgentes # 3877, Col. La Fama, ZIP Code 
14269, Delegacion Tlalpan, Mexico City, Mexico and 15Dept. of Mental Health, Namdi Azikiwe University Teaching Hospital, Nnewi, Anambra 
State, Nigeria
Email: Martin J Prince* - m.prince@iop.kcl.ac.uk; Juan Llibre de Rodriguez - mguerra@infomed.sld.cu; L Noriega - mguerra@infomed.sld.cu; 
A Lopez - mguerra@infomed.sld.cu; Daisy Acosta - daisyacosta@verizon.net.do; Emiliano Albanese - e.albanese@iop.kcl.ac.uk; 
Raul Arizaga - raularizaga@fibertel.com.ar; John RM Copeland - jrmcop@btinternet.com; Michael Dewey - m.dewey@iop.kcl.ac.uk; 
Cleusa P Ferri - cleusa.ferri@iop.kcl.ac.uk; Mariella Guerra - magasc@terra.com.pe; Yueqin Huang - dengy@mail.tsinghua.edu.cn; 
KS Jacob - ksjacob@cmcvellore.ac.in; ES Krishnamoorthy - krish@neurokrish.com; Paul McKeigue - paul.mckeigue@ed.ac.uk; 
Renata Sousa - r.sousa@iop.kcl.ac.uk; Robert J Stewart - spjurjs@iop.kcl.ac.uk; Aquiles Salas - aquiles@cantv.net; 
Ana Luisa Sosa - drasosa@hotmail.com; Richard Uwakwa - ruwakwe2001@yahoo.com
* Corresponding author    
Abstract
Background: The criterion for dementia implicit in DSM-IV is widely used in research but not fully
operationalised. The 10/66 Dementia Research Group sought to do this using assessments from
their one phase dementia diagnostic research interview, and to validate the resulting algorithm in
a population-based study in Cuba.
Methods:  The criterion was operationalised as a computerised algorithm, applying clinical
principles, based upon the 10/66 cognitive tests, clinical interview and informant reports; the
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Community Screening Instrument for Dementia, the CERAD 10 word list learning and animal
naming tests, the Geriatric Mental State, and the History and Aetiology Schedule – Dementia
Diagnosis and Subtype. This was validated in Cuba against a local clinician DSM-IV diagnosis and the
10/66 dementia diagnosis (originally calibrated probabilistically against clinician DSM-IV diagnoses
in the 10/66 pilot study).
Results: The DSM-IV sub-criteria were plausibly distributed among clinically diagnosed dementia
cases and controls. The clinician diagnoses agreed better with 10/66 dementia diagnosis than with
the more conservative computerized DSM-IV algorithm. The DSM-IV algorithm was particularly
likely to miss less severe dementia cases. Those with a 10/66 dementia diagnosis who did not meet
the DSM-IV criterion were less cognitively and functionally impaired compared with the DSMIV
confirmed cases, but still grossly impaired compared with those free of dementia.
Conclusion: The DSM-IV criterion, strictly applied, defines a narrow category of unambiguous
dementia characterized by marked impairment. It may be specific but incompletely sensitive to
clinically relevant cases. The 10/66 dementia diagnosis defines a broader category that may be more
sensitive, identifying genuine cases beyond those defined by our DSM-IV algorithm, with relevance
to the estimation of the population burden of this disorder.
Background
Unlike its predecessor DSM III-R [1], DSM-IV [2] does not
specify a criterion for the diagnosis of dementia. However,
this can be inferred from the common elements of the
DSM-IV criteria for each of the dementia sub-type diag-
noses. These are as follows:
The criteria (A-D) must all be satisfied
A. The development of multiple cognitive deficits mani-
fested by both
1. memory impairment (impaired ability to learn new
information or to recall previously learned information)
2. one (or more) of the following cognitive disturbances:
a. aphasia (language disturbance)
b. apraxia (impaired ability to carry out motor activities
despite intact motor function)
c. agnosia (failure to recognize or identify objects despite
intact sensory function)
d. disturbance in executive functioning (i.e., planning,
organizing, sequencing, abstracting)
B. The cognitive deficits in Criteria A1 and A2 each
1. cause significant impairment in social or occupational
functioning, and
2. represent a significant decline from a previous level of
functioning.
C. The deficits do not occur exclusively during the course
of a delirium.
D. The disturbance is not better accounted for by another
axis I disorder (for example, major depressive disorder,
schizophrenia)
This criterion has been widely used in both clinical and
epidemiological research. There is strong face validity. It
defines a progressive and relatively pervasive disorder. It
seeks to distinguish between dementia on the one hand,
and potentially remediable cognitive impairment arising
from delirium or mental disorder on the other. Its ele-
ments are, for the most part, objectively verifiable. The
main weakness is the lack of operational definition. What
constitutes memory impairment, or cognitive disturbance?
What is a significant impairment in functioning? What rep-
resents a significant decline in functioning? When is the
disturbance better accounted for by another axis one disor-
der? The usual practice is for these questions to be settled
according to clinical judgment (in research often by a con-
sensus panel of expert diagnosticians). However, even
when structured assessments have been used, the lack of
clarity in these areas introduces much scope for unreliabil-
ity. For the older DSMIII-R criteria, reliability was poorer
between as opposed to within international research
teams [3]. A WHO assessment of cross-national reliability
of application of the DSM-IIR criteria identified worry-
ingly poor reliability for certain elements [4].
The 10/66 Dementia Research Group has as one of its
main objectives to compare the distribution and determi-
nants of dementia in different world regions. We have
already described an approach for identifying persons
with probable dementia in a one phase study design,BMC Public Health 2008, 8:219 http://www.biomedcentral.com/1471-2458/8/219
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using a probabilistic predictive algorithm for '10/66
dementia' derived and tested against the criterion of DSM-
IV dementia [5]. The algorithm seemed relatively 'educa-
tion-fair', that is the false positive rate among those with
low levels of education was low, and validity was estab-
lished for a variety of countries and cultures. 10/66 DRG
population-based studies are now underway in Cuba, Bra-
zil, Dominican Republic, Venezuela, Mexico, Argentina,
Peru, India, China and Nigeria. We also wished to apply
DSM-IV criterion directly, and had extended the scope of
our one phase assessment to ensure that the necessary
data were recorded. The purpose of this paper is to
describe our full computerized operationalisation of the
DSM-IV criterion, and then to test its validity against local
clinician dementia diagnosis and the 10/66 dementia
diagnosis, using data from the Cuban population-based
study.
Methods
Design
We have previously published a comprehensive descrip-
tion of the full protocol for the 10/66 population-based
surveys [6]. In the Cuban 10/66 population-based study
participants were recruited from eight catchment areas
defined by proximity to polyclinics in Havana city and
Matanzas. All those aged 65 and over living within the
catchment area boundaries were included. Eligible partic-
ipants were identified from polyclinic registers backed up
by systematic door knocking of all households within the
catchment area. The DSM-IV dementia and 10/66 demen-
tia survey diagnoses were derived from the structured
assessments described below using computerized algo-
rithms, which were run when the full survey was com-
pleted. In six of the eight Cuban catchment areas, all
participants were interviewed by polyclinic psychiatrists
and physicians (one for each catchment area) who were
experienced dementia diagnosticians. They were asked to
make clinical dementia diagnoses according to DSM-IV
criteria, at the end of each individual assessment. At this
point, the clinician could not have been aware of the out-
put of the computerized 10/66 and DSM-IV algorithms,
and, given their complexity, would have found it difficult
to guess the result. This clinical diagnosis was then used as
the criterion validation for the computerized DSM-IV
algorithm, described below. We also examined the corre-
spondence between the 10/66 Dementia Diagnostic algo-
rithm and clinical diagnosis, and, in the full sample,
between the DSM-IV computerized algorithm and the 10/
66 Dementia Diagnostic algorithm.
Measures
The individual cognitive tests used in the 10/66 popula-
tion-based studies were all validated against a dementia
criterion in the earlier pilot phase of the 10/66 pro-
gramme [5].
1) The Community Screening Interview for Dementia
(CSI 'D') [7] consists of a 32 item cognitive test adminis-
tered to the participant (20 minutes) and a 26 item
informant interview, enquiring after the participant's
daily functioning and general health (15 minutes). Three
summary scores can be generated from the CSI 'D'; a) The
cognitive score (COGSCORE), a summary score from the
participant cognitive test, with different weightings
applied to some items b) The informant score (RELS-
CORE) an unweighted total score from the informant
interview and c) The discriminant function score (DFS-
CORE), combining COGSCORE and RELSCORE into a
single score, using the formula DFSCORE = 0.452322 –
(0.01669918*COGSCORE) + (0.03033851*RELSCORE).
For the COGSCORE and DFSCORE there are validated
cutpoints suggestive of probable and possible cases of
dementia.
2) The animal naming verbal fluency task [8] from the
Consortium to Establish a Registry for Alzheimer's Dis-
ease (CERAD) test battery. Participants are encouraged to
name as many different animals as they can in the space
of one minute.
3) The adapted CERAD ten word list learning task
improved the discrimination of the Hindi Mental State
Examination in the Indo-US Ballabgarh dementia study
[9]. Six words were taken from the original CERAD battery
English language list; butter, arm, letter, queen, ticket, and
grass. Pole, shore, cabin, and engine were replaced with
corner, stone, book and stick, which were deemed more
culturally appropriate [9]. In the learning phase, the list is
read out to the participant, who is then asked to recall
straight away the words that they remember. This process
is repeated three times, giving a total learning score out of
30. Five minutes later the participant is again asked to
recall the 10 words, giving a delayed recall score out of 10.
4) The Geriatric Mental State (GMS/AGECAT) [10,11].
This clinical interview generates, from a computerised
algorithm (AGECAT) levels of psychopathology (0 = non-
case, 1 and 2 = subcase, 3, 4 and 5 = mild moderate and
severe case) within nine diagnostic clusters; organic brain
syndrome (dementia), schizophrenia, mania, neurotic
and psychotic depression, obsessional, hypochondriacal,
phobic and anxiety neuroses.
These assessments were supplemented by a structured
physical and neurological assessment and an extended
informant interview, the History and Aetiology Schedule
– Dementia Diagnosis and Subtype (HAS-DDS), a modi-
fication of the earlier HAS [12] to focus specifically on
information relevant to DSM-IV dementia diagnostic cri-
teria [2], and for dementia subtype diagnosis. With refer-
ence to the DSM-IV dementia criteria the HAS-DDSBMC Public Health 2008, 8:219 http://www.biomedcentral.com/1471-2458/8/219
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covered the onset and course of the reported cognitive/
functional impairment, evidence of impairment in gnosis,
praxis and executive function, and the presence or absence
of delirium.
Three further assessments not included in either the DSM-
IV or 10/66 algorithms were used to test for concurrent
validity. These were:
1) activity limitation and participation restriction meas-
ured by the WHO-DAS II [13], developed by the WHO as
a culture-fair assessment tool for use in cross-cultural
comparative epidemiological and health services research;
2) behavioural and psychological symptoms of dementia
assessed by the Neuropsychiatric Inventory (NPI-Q)[14];
3) dependency (whether the participant needed no care,
some care or much care) ascertained by a series of open-
ended questions administered to the informant.
We assessed the severity of dementia in all participants
using a computerised operationalisation of the Clinical
Dementia Rating (CDR) [15].
10/66 dementia diagnosis
10/66 dementia diagnosis is defined as those scoring
above a cutpoint of predicted probability of DSM-IV
Dementia syndrome [2] from the logistic regression equa-
tion developed in the 10/66 international pilot study,
using coefficients from the GMS, CSI-D informant and
cognitive test interviews and the modified CERAD 10
word list learning tasks [5].
Operationalisation of the DSM-IV criteria for the 
computerised DSM-IV algorithm
We settled on a 'top down' approach in which we
reviewed the data available in the 10/66 population-
based study interview and mapped the information col-
lected onto the DSM-IV criterion applying clinical princi-
ples. We sought to operationalise the decision-making
process of a competent clinician.
Criterion A1 (memory impairment)
Memory was assessed objectively by several items in the
CSI'D', which were summed to form a memory subscale,
and by the CERAD 10 word list with immediate learning
and delayed recall. Three memory scores were thus
derived. Additionally, at the end of the GMS interview the
interviewer makes an objective rating of memory func-
tion. Finally, in the informant section of the CSI'D', the
informant is asked about declining memory in general,
and the frequency of six specific and characteristic mem-
ory lapses; forgetting where s/he has put things, where
things are kept, names of friends, names of family, when
s/he last saw informant, and what happened the day
before.
To define impairment on memory tests, we used the
threshold applied in the criterion for mild cognitive
impairment; 1.5 standard deviations below the mean for
non-demented persons. We differ from the MCI criteria in
using education as well as age specific norms. Memory
function in older people free of dementia is strongly influ-
enced by level of education, and it seemed important to
identify memory impairment only among those perform-
ing worst than most of their peers. 1.5 standard deviations
below the mean corresponds approximately to the 7th
centile of a normal distribution. While it was judged
important to set the threshold at the level of mild impair-
ment to ensure sensitivity for detection of early dementia,
impaired performance on one test may be explained by
extraneous factors; consistent poor performance is much
more likely to reflect genuine impairment. In our algo-
rithm, the presence of more unequivocal cognitive
impairment on multiple objective tests lowers the degree
of corroboration required from the informant report, and
vice versa. At the extremes, consistent cognitive impair-
ment on testing means that the criterion is met even in the
absence of informant report, and very high levels of
informant reported impairment mean that the criterion is
met even in the absence of evidence of impairment on for-
mal testing.
Criterion A2 (at least one of aphasia, apraxia, agnosia or disturbance 
in executive functioning)
With the 10/66 assessments, impairment in each of these
domains of cognitive functioning can be established
through objective cognitive tests, and informant opinion
of recent decline.
a) Criterion A2a. Aphasia
Both language expression and comprehension are tested
in the CSI'D', yielding a six point language subscale. In
our pilot study this was somewhat lacking in variance,
with a pronounced ceiling effect, and with little effect of
age and education. Therefore the same cutpoints were
applied to all participants, but as for memory impair-
ment, more convincing evidence of impairment on for-
mal testing lowered the threshold for supporting
informant reports, and vice versa.
b) Criterion A2b. Apraxia
Praxis was tested by three items in the CSI'D'; taking a
sheet of paper, folding it in half and placing it in the lap,
and copying interlocking circles and pentagons. These
items were used to construct a five point apraxia scale.
Two informant report items in the CSI'D' were relevant,
those referring to difficulty feeding and difficulty dressing,
not explained by physical disability. Here, given the gen-BMC Public Health 2008, 8:219 http://www.biomedcentral.com/1471-2458/8/219
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erally poor performance on the praxis test items of those
with little education, apparent impairment on formal test-
ing only fulfils the criterion if corroborated by an inform-
ant report of at least some degree of impairment
c) Criterion A2c. Agnosia
In the CSI'D' the participant is asked to recognize and
name four objects (pencil, watch, chair, and shoe) and
three parts of the body (knuckle, elbow and shoulder)
generating a seven point agnosia scale. In addition, in our
extended informant interview, the informant is asked if
the participant misidentifies family or friends. The crite-
rion is fulfilled if the informant reports misidentification
and/or if two or more errors are made on formal testing.
d) Criterion A2d. Disturbance in executive functioning
Executive functioning was tested using the palm-fist-hand
test from the Luria battery of frontal lobe tasks, and also
by the animal naming test (testing verbal fluency) from
the CERAD battery. In the case of the animal naming test,
with much of the variance explained by age and education
in non-demented persons, we again used 1.5 standard
deviations below the age and education norm as the
threshold for impairment. In the informant section of the
CSI'D' the informant was asked whether the participant
experienced difficulty in adjusting to change in routine
(frequently or occasionally) and whether there was a
change in their ability to think and reason. As part of our
extended informant interview we also enquired after diffi-
culty in making decisions, and whether thinking had
seemed muddled. Informant reports on these four aspects
of executive function were formed into an ad hoc inform-
ant scale. Given the lack of domain specificity of the ani-
mal naming test (impaired for example by poor
concentration) the sub-criterion was not considered to be
fulfilled unless impairment in this test was corroborated
by some degree of executive impairment reported by the
informant. Failure on the palm-fist-hand test was consid-
ered sufficient in itself.
Criterion B1
This criterion requires that the cognitive deficits in Criteria
A1 and A2 each cause significant impairment in social or
occupational functioning. Several of the Geriatric Mental
State items elicit self-reported memory impairment,
including impact on functioning. The participant is asked
if memory impairment is a problem for him/her, if they
forget names of family or close friends, if they forget
where they have placed things, and if they have to make a
greater effort to remember things. These items are only
rated positive if they occur frequently and cause regular
inconvenience. One informant (CSI'D') item is also rele-
vant, where the informant is asked whether memory is a
particular problem for the participant. Several CSI'D'
items address general impairment in social and occupa-
tional functioning likely to have arisen as a consequence
of impairment in language, praxis, gnosis or executive
function; that is, diminution in range of activities and/or
reduced ability to carry out activities, loss of hobby or
skills, problems with household chores (not accounted
for by physical disability), change in ability to handle
money, getting lost inside of the home or in the commu-
nity. The B1 criterion was considered to be present where
the participant or the informant reported memory impair-
ment that was hindering real-life functioning, and the
informant reported one or more examples of general
social/occupational impairment.
Criterion B2
This criterion requires that the cognitive deficits described
in A1 and A2 represent a significant decline from a previ-
ous level of functioning. In the absence of repeated meas-
ures of cognitive function, the only recourse is to the
informant history. In the CSI'D' the informant is asked if
there has been 'a change in activities', and a 'general
decline in mental function'. The HAS-DDS, introduced for
the population-based studies to define more precisely
course and outcome asks the informant whether overall
deterioration, overall improvement or no change has
occurred since the onset of the condition, whether there
has been gradual decline over a period of two or more
years, and whether the intellectual impairment dates from
birth or pathology earlier in life. The criterion is estab-
lished if the informant reports either 'a change in activi-
ties', or a 'general decline in mental function' or an overall
deterioration or gradual decline over two or more years,
provided that the impairment is not considered to date
from birth or early life.
Criterion C
This criterion requires that the deficits do not occur exclu-
sively during the course of a delirium. Information rele-
vant to this criterion is gathered in the HAD-DDS from an
informant; time of onset, type of onset, onset as a result of
stroke, presence or absence of clouding of consciousness
and confusion worse towards the end of the day. Our
algorithm determines that the deficits do occur exclusively
in the course of a delirium if the onset was in the last
month with sudden onset over 1–3 days, and with either
clouding of consciousness (the HAS-DDS item 'changea-
ble over 24 hours, alert at one time, drowsy and confused
the next') or confusion worse towards night or evening.
Criterion D
This criterion requires that the disturbance is not better
accounted for by another axis I disorder (for example,
major depressive disorder, schizophrenia). Our algorithm
determines that the disturbance is better accounted for by
another axis 1 disorder if the stage 2 GMS/AGECAT diag-
nosis is either schizophrenia or depression, and dementiaBMC Public Health 2008, 8:219 http://www.biomedcentral.com/1471-2458/8/219
Page 6 of 12
(page number not for citation purposes)
diagnosis is not confirmed by the 10/66 dementia diag-
nostic algorithm.
Analyses
10/66 dementia algorithm cases, and DSM-IV cases are
compared with the Cuban clinician interviewers judg-
ment of dementia caseness as an external criterion, with
sensitivity, specificity and kappa for agreement.
The prevalence of the DSM-IV sub-criteria and their indi-
vidual elements is compared between clinically diagnosed
dementia cases and high education and low education
controls, free of dementia in the 10/66 Cuban popula-
tion-based study data sets.
10/66 Dementia cases, not confirmed by the DSM-IV
computerized algorithm are compared with confirmed
DSM-IV cases and controls free of dementia according to
the following characteristics; mean CSI'D' COGSCORE
and RELSCORE, NPI-Q (behavioural and psychiatric
symptoms of dementia) severity and distress scores [14],
WHODAS II disability [13], Clinical Dementia Rating
(CDR) [15] and the frequency of reports of needing much,
some or no care; using independent sample t-tests, and
Chi squared tests for trend as appropriate.
Results
In Cuba, 2909 interviews were completed with 96.4% of
all eligible persons responding. All non-response was
accounted for by refusals.
In six of the eight Cuban catchment areas, all participants
(n = 1887) were interviewed by clinicians who were expe-
rienced dementia diagnosticians. 147 (7.8%) were identi-
fied by the clinicians as dementia cases, leaving 776 low
education controls (completed primary or less) and 958
high education controls (completed secondary or more).
After processing our survey data, we identified among
these 1887 participants 192 dementia cases according to
the 10/66 algorithm (10.2%) and 114 cases according to
the computerised DSM-IV dementia algorithm (6.0%).
Agreement with the clinician diagnosis was better for 10/
66 dementia (Kappa 0.79 [95% CI 0.74–0.83], sensitivity
93.2%, specificity 96.8%) than for the DSM-IV computer-
ised algorithm (Kappa 0.63 [95% CI 0.56–0.69], sensitiv-
ity 57.8%, specificity 98.3%). Across the six polyclinic
centres, Kappas ranged from 0.63 to 0.86 for 10/66
dementia (median 0.81) and from 0.55 to 0.77 for DSM-
IV dementia (median 0.60). According to the CDR sever-
ity of the clinically diagnosed cases, the DSM-IV criterion
confirmed 86.7% of severe cases, 78.1% of moderate
cases, 65.4% of the mild cases and none of the questiona-
ble cases. The 10/66 algorithm identified 100.0% of
severe cases, 100.0% of moderate cases, 98.1% of mild
cases and 77.4% of questionable cases.
Seventy-one percent of the clinically diagnosed cases met
the A1 memory impairment criterion, an essential
requirement for a DSM-IV diagnosis, 95% had impair-
ments in one or more other domains of cognitive function
(A2). All of the sub-criteria for cognitive impairment (A1
and A2) had a very low prevalence in the control groups,
suggesting high specificity (Table 1). The only exception
was that of the palm-fist-hand test from the Luria battery
testing executive function which was frequently 'failed' by
those free of dementia. Consequently, more than one
third of low education controls and nearly one fifth of
high education controls also met the A2 sub-criterion.
However, this had little impact on the overall specificity of
the A criterion given the high specificity of the memory
sub-criterion. 85% met DSM-IV sub-criterion for social
and occupational impairment (B1), and 82% met sub-cri-
terion for decline (B2) (Table 2). Combining these two
elements, 73% of clinically diagnosed cases met the B cri-
terion compared with around one tenth of high and low
education controls. No participants were identified as suf-
fering from delirium (Table 3). Only 1% of the clinically
diagnosed cases were classified by the DSM-IV algorithm
as 'better accounted for by another Axis 1 disorder' (Table
4). The distribution of DSM-IV sub-criteria by 10/66
dementia caseness was very similar to that previously
observed for the clinician diagnoses (Table 5).
In the full sample of 2909 participants, 181 of the 315 10/
66 dementia cases (58%) were confirmed as cases by the
computerised DSM-IV algorithm. Compared with 10/66
dementia cases not meeting DSM-IV criteria, those with
DSM-IV dementia were more cognitively impaired, had
more cognitive and functional impairment according to
the informant, were more disabled, had more Behavioural
and Psychological Symptoms of Dementia and more con-
sequent caregiver distress, and greater needs for care
(Table 6). The Clinical Dementia Rating severity of the
DSM-IV cases was also more severe – 0.5% had question-
able dementia, 43.9% mild dementia, 31.2% moderate
dementia and 24.3% severe dementia, compared with
50.8% questionable, 34.1% mild, 9.1% moderate and
6.1% severe for the 10/66 cases not confirmed by DSM-IV.
However, the 10/66 dementia cases that were not con-
firmed by DSM-IV were much more similar in all of these
respects to the DSM-IV cases than to the non-demented
controls. Using Scheffe's test for multiple group compari-
sons and Kruskal Wallis (non-parametric test based on
group ranks), all group differences were statistically signif-
icant at p < 0.001 (Table 6).
Discussion
The sub-criteria for DSM-IV dementia, derived from a
computerised algorithm were plausibly distributed in
dementia cases (both those identified by clinician diagno-
sis, and by the 10/66 dementia algorithm) and non-cases.BMC Public Health 2008, 8:219 http://www.biomedcentral.com/1471-2458/8/219
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Table 1: Operationalised criteria for memory impairment (A1), and other domains of cognitive impairment (A2), when applied to the 
Cuban population based study data set, by clinical dementia status
Prevalence (%) in those 
with clinically diagnosed 
dementia
Prevalence (%) 
(high education 
controls)
Prevalence (%) 
(low education 
controls)
A1 Memory impairment (must be present)
A1_1 > 1.5 standard deviations below the mean for their age and education 
group (among those free from dementia) on all three tests of memory and/or
37 2 2
A1_2 > 1.5 standard deviations below the mean for their age and education 
group on at least two tests of memory and at least two memory lapses reported 
by informant, of which one should occur 'frequently' and/or
55 3 3
A1_3 > 1.5 standard deviations below the mean for their age and education 
group on at least one test of memory and at least three memory lapses 
reported by informant, of which at least two should occur 'frequently' and/or
69 3 4
A1_4 >= four memory lapses are reported by informant, of which at least three 
occur 'frequently' and/or
78 4 5
A1_5 Severe memory impairment rated by the GMS interviewer 51 1 2
A1 OVERALL 71 3 3
A2 – language impairment, apraxia, agnosia and executive impairment – at least one must be present
A2a. Language impairment
Score of <= 4 on CSI'D' language subscale and/or 32 2 2
Score of <= 5 on CSI'D' language subscale and informant reports that participant 
'sometimes' or 'frequently' uses wrong words or has difficulty saying words, and/
or
22 1 1
informant reports that participant 'frequently' uses wrong words or has difficulty 
saying words
23 1 1
A2a OVERALL 52 2 3
A2b. Apraxia
Unable to dress, or wrong sequence/forgets items (DRESS >= 2) and/or 22 0 1
Cannot eat cleanly with proper utensils (FEED >= 1) and/or 20 1 1
Apraxia score <= 3 and some impairment in dressing or feeding (DRESS or 
FEED >= 1)
29 1 2
A2b OVERALL 31 1 2
A2c. Agnosia
the informant reports that the participant misidentifies family or friends and/or 27 1 1
five or fewer of the seven objects/body parts are named correctly 33 2 4
A2C OVERALL 43 3 5
A2_d Executive function
participant cannot learn palm-fist-hand after five trials and/or 52 7 15
participant cannot sequence palm-fist-hand and/or 69 9 25
informant reports that participant 'frequently' has difficulty in adjusting to 
routine and/or
25 7 8
informant reports any degree of impairment in three or more of the four 
examples of executive function
52 2 3
informant reports some degree of impairment in two or more of the four 
examples of executive function and the participant scored more than 1.5 
standard deviations below the mean for their age and education group (among 
those free from dementia) on the animal naming test
46 1 1
A2_d OVERALL 93 16 31BMC Public Health 2008, 8:219 http://www.biomedcentral.com/1471-2458/8/219
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Table 3: Operationalised criteria for delirium (C) 1, when applied to the Cuban population based study data set, by clinical dementia 
status
Prevalence (%) in those with 
clinically diagnosed dementia N = 
130
Prevalence (%) (high education 
controls) N = 50
Prevalence (%) (low education 
controls) N = 95
C criterion requires that the deficits do not occur exclusively during the course of a delirium
C_1 no onset in the last month, 
and
100 98 100
C_2 no sudden onset in 1–3 days, 
and
93 94 93
C_3 not changeable over 24 hours, 
alert at one time, drowsy and 
confused the next, or
75 85 87
C_4 no confusion worse towards 
night or evening
52 70 61
1. Only ascertained among those with a current episode characterized by functional and cognitive decline
Table 2: Operationalised criteria for impairment in functioning (B1), and decline from a previous level of functioning (B2) when applied 
to the Cuban population based study data set, by clinical dementia status
Prevalence (%) in those with 
clinically diagnosed dementia
Prevalence (%) (high education 
controls)
Prevalence (%) (low education 
controls)
B1 criterion requires that the cognitive deficits in Criteria A1 and A2 each cause significant impairment in social or occupational 
functioning
Memory impairment reported by 
informant, or
77 7 11
problems in two or more memory 
areas by informant report at least 
one of which must be 'frequent', or
90 26 32
any significant self-reported 
memory impairment (Q341, 
Q351, Q352 or Q361 >= 1)
69 65 66
Any of the above memory 
impairments, and
95 67 69
General impairment – one or 
more informant reported deficits 
(reduced activities, loss of hobby 
or skills, problems with household 
chores, change in ability to handle 
money, gets lost in the community 
or at home)
88 11 16
B2 criterion requires that the cognitive deficits described in A1 and A2 represent a significant decline from a previous level of functioning
B2_1 a 'change in activities', and/or 68 7 11
B2_2 a 'general decline in mental 
function' and/or
80 6 9
B2_3 an overall deterioration and/
or
83 5 7
B2_4 gradual decline over two or 
more years, and
71 4 6
B2_5 the impairment is not 
considered to date from birth or 
early life
100 100 100BMC Public Health 2008, 8:219 http://www.biomedcentral.com/1471-2458/8/219
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Over 80% of cases met the key A1, A2, B1 and B2 sub-cri-
teria, the sole exception being that of A1, met by 71% of
10/66 algorithm cases. The requirement that each of the
A1, A2, B1 and B2 sub-criteria are met accounts for the rel-
atively low proportion, 58%, of clinically diagnosed
dementia cases meeting all elements of the computerised
DSM-IV criterion. On the one hand the stringency of this
approach ensures high specificity; on the other, misclassi-
fication error will tend to accumulate reducing the sensi-
tivity of the overall DSM-IV algorithm. We acknowledge a
potential weakness of our approach in that the clinical
diagnosis, the computerised DSM-IV diagnosis and the
10/66 diagnosis were all derived from elements of the
same structured clinician assessment. This may have led to
an overestimate of their concordance. Formal validation
would have required independent clinical assessments of
survey participants by expert clinicians, applying DSM-IV
criteria but without relying upon our survey assessments
to do so; however, this approach would still not address
the problem of unreliability in clinician application of the
DSM-IV criteria.
We have intentionally avoided describing any of the diag-
nostic outcomes in this study as a 'gold standard', prefer-
ring instead to explore the underlying dementia construct
and its measurement through the relationships observed
Table 5: Summary of performance of DSM-IV Algorithm in Cuban population based data set, when applied to the Cuban population 
based study data set, by dementia status according to clinical diagnosis and 10/66 dementia algorithm
DSM-IV criterion Dementia diagnosis Prevalence (%) in those 
with dementia
Prevalence (%) (high 
education controls)
Prevalence (%) (low 
education controls)
Criterion A1: Memory impairment Clinical 71 3 3
10/66 71 2 2
Criterion A2: Impairment in other 
cognitive function
Clinical 95 17 33
10/66 96 17 37
Criterion A (A1+A2) Clinical 70 2 3
10/66 70 1 1
Criterion B1: Impaired social/
occupational functioning
Clinical 85 9 14
10/66 90 10 14
Criterion B2: Decline from a 
previous level of functioning
Clinical 82 10 14
10/66 85 12 15
Criterion B B1+B2 Clinical 73 7 9
10/66 79 8 8
Criterion C: Deficits do not occur 
only in delirium
Clinical 100 100 100
10/66 100 100 100
Criterion D: Disturbances not 
better accounted for by another 
axis 1 disorder
Clinical 99 74 67
10/66 n/a 71 65
OVERALL (A+B+C+D) Clinical 58 1 2
10/66 58 0 0
Table 4: Operationalised criteria for alternative cause (D), when applied to the Cuban population based study data set, by clinical 
dementia status
Prevalence (%) in those with 
clinically diagnosed dementia
Prevalence (%) (high 
education controls)
Prevalence (%) (low 
education controls)
D criterion requires that the disturbance is not better accounted for by another axis I disorder (for example, major depressive disorder, 
schizophrenia)
D-1 No AGECAT stage 2 diagnosis 
of 'schizophrenia' or
Clinical 99 100 100
D_2 No AGECAT stage 2 diagnosis 
of 'depression' and
Clinical 93 74 67
D_3 Dementia diagnosis confirmed 
by 10/66 algorithm
Clinical 97 2 4BMC Public Health 2008, 8:219 http://www.biomedcentral.com/1471-2458/8/219
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between the three outcomes; the 10/66 dementia and
DSM-IV dementia survey diagnoses and the clinician diag-
nosis. In reality, each has their strengths and their weak-
nesses. The DSM-IV criteria are the dominant paradigm in
current research and clinical practice, but have been cri-
tiqued both for the primacy accorded to memory impair-
ment (a necessary component, which is not, however, a
prominent early feature of many dementias, for example
vascular dementia and frontotemporal dementia) and for
the lack of specificity of the secondary cognitive criteria
(aphasia, apraxia, agnosia, disturbance in executive func-
tioning) which are arguably of more direct relevance to
stroke than to dementia [16]. We are optimistic that our
10/66 dementia diagnosis provides a robust alternative
given its careful cross-cultural development and calibra-
tion [5]; however, it has not previously been validated in
a community setting. Local clinician diagnoses have
strong ecological validity, reflecting as they do local clini-
cal practice. Nevertheless, lack of standardisation may
lead to problems with reliability and validity. In the
absence of an unimpeachable gold standard, our
approach has therefore been closer to that of construct
validation as described by Cronbach and Meehl [17] than
to criterion validation.
What then have we learnt from this exercise regarding the
comparative utility of the 10/66 and DSM-IV diagnoses?
Comparison of the characteristics of 10/66 Dementia
Algorithm cases confirmed and not confirmed by our
computerised DSM-IV algorithm does raise some ques-
tions regarding the sensitivity of the DSM-IV criterion, in
that many unconfirmed 10/66 cases were still grossly
impaired compared with the controls who met neither set
of criteria. Furthermore, in Cuba, clinician diagnoses
matched more closely to our 10/66 dementia category
than to the more restrictive DSM-IV computerised crite-
rion. In principle, the clinician diagnoses were made
using the DSM-IV criterion. Clinicians may be less strin-
gent in the thresholds they set for clinical significance, and
less rigorous than a computerised system in the applica-
tion of the algorithm. In either event, our Cuban data
tends to suggest that clinically relevant dementia may be
prevalent beyond the confines of the narrowly defined
DSM-IV criterion when, as in our study, it is strictly
applied using a fully-operationalised computerised algo-
rithm. One of the few population-based studies to exam-
ine this issue directly, the Canadian Study of Health and
Aging [18] reported a prevalence of 20.9% for those aged
65 and over according to clinical consensus compared
with 13.7% according to DSM-IV criterion. Mild cases
were selectively excluded by the DSM-IV criterion. We
found the same. This may have important implications
for previous assessments of the global prevalence of
dementia [19,20], relying as they do, to a large extent,
upon studies that have used the DSM-IV criterion. The
more inclusive 10/66 dementia diagnosis may help to
establish the true population burden of the dementia syn-
drome. Conversely, our 10/66 Dementia algorithm may
Table 6: Concurrent validation of 10/66 Dementia and DSM-IV dementia diagnoses
Group 1 (n = 
2587) Non-cases
Group 2 (n = 134) 
10/66 cases not 
confirmed by 
DSM-IV
Group 3 (n = 188) 
DSM-IV cases
Mean difference 
(group 2 vs group 
1)
Mean difference 
(group 2 vs group 3)
CSI'D' 
COGSCORE 
(cognitive test 
score)
Mean (95% CI) 30.6 (30.5–30.6) 22.4 (21.3–23.7) 17.1 (15.9–18.3) -8.1 (-6.9 to -9.3) 5.4 (3.7 to 7.1)
Median (IQR) 31.0 (29.6–32.1) 23.9 (20.7–27.2) 16.6 (12.3–23.4)
CSI'D'RELSCORE(
informant reports 
of cognitive and 
functional decline)
Mean (95% CI) 1.1 (1.0–1.2) 8.3 (7.3–9.3) 15.4 (14.5–16.3) 7.2 (6.2 to 8.2) -7.1 (-5.8 to -8.5)
Median (IQR) 0.5 (0.0–1.5) 7.5 (5.5–10.0) 14.3 (10.0–20.0)
NPI-Q Severity 
(severity of 
behavioural and 
psychological 
symptoms)
Mean (95% CI) 2.0 (1.9–2.1) 5.0 (4.1–5.9) 7.1 (6.3–7.9) 3.0 (2.2 to 3.9) -2.1 (-0.9 to -3.2)
Median (IQR) 1 (0–3) 3 (1–8) 7 (2–11)
NPI'Q' Distress 
(distress caused 
to the caregiver 
by BPSD)
Mean (95% CI) 1.7 (1.6–1.9) 5.0 (3.9–6.1) 7.3 (6.3–8.4) 3.3 (2.2 to 4.3) -2.3 (-0.8 to -3.8)
Median (IQR) 0 (0–2) 3 (0–7) 5 (1–12)
WHODAS II 
Disability
Mean (95% CI) 9.6 (9.1–10.2) 36.0 (30.8–41.2) 48.7 (44.0–53.3) 26.4 (21.2 to 31.6) -12.7 (-5.7 to -19.7)
Median (IQR) 2.8 (0.0–13.9) 26.4 (8.3–63.2) 50.0 (19.4–77.8)
Needs for care No care needed 96.6% 58.7% 29.8% Chi sq = 1043, 1 df, p < 0.001
Needs care some 
of the time
1.9% 11.6% 15.2%
Needs care much 
of the time
1.4% 29.8% 55.1%BMC Public Health 2008, 8:219 http://www.biomedcentral.com/1471-2458/8/219
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be overdiagnosing dementia. Our earlier pilot study to
develop and test the 10/66 algorithm against a DSM-IV
criterion, suggests that this is possible; we achieved very
high sensitivity (94%), but with a 6% false positive rate in
low education controls and 3% FPR in high education
controls. We will examine these issues carefully in each of
the 10/66 population-based study centres. The relative
validity of the two computerised diagnoses used in the 10/
66 survey can probably best be settled when their predic-
tive validity is addressed in the forthcoming incidence
phase of the 10/66 investigations. Those with dementia
would be expected to have declined further, or to have
died. Stability or improvement in cognitive function and
functional status would argue against the validity of the
case definitions.
Conclusion
We have at least partly established the validity of the com-
puterised DSM-IV algorithm in Cuba. While we cannot
assume that this will extend to other 10/66 centres, core
face validity is also strong. Clinical principles have been
applied by experienced clinicians in the 10/66 group. The
operationalisation, and the basis of the decisions that
were taken is transparent. The algorithm is described in
this paper, and the full computerised algorithm can be
obtained on request from the authors.
Abbreviations
1066 DRG: Dementia Research Group; AD: Alzheimer
Disease; ADI: Alzheimer Disease International; AGECAT:
Automated Geriatric Examination for Computerised
Assisted Taxonomy; APOE: apolipoprotein E;  BPSD:
Behavioural and Psychological Symptoms of Dementia;
CERAD: Consortium to Establish a Registry for Alzhe-
imer's Disease; CDR: Clinical Dementia Rating;
COGSCORE: CSI'D' cognitive function score; CSI-D:
Community Screening Interview for Dementia; DFS-
CORE: CSI'D' discriminant function score; DSM: Diag-
nostic and Statistical Manual of Mental Disorders; GMS:
Geriatric Mental State; HAS-DDS: History and Aetiology
Schedule Dementia Diagnosis and Subtype; NPI-Q: Neu-
ropsychiatric inventory; RELSCORE: CSI'D' informant
score; WHO-DAS: World Health Organization – Disabil-
ity assessment schedule.
Competing interests
The 10/66 Dementia Research Group works closely with
Alzheimer's Disease International (ADI), the non-profit
federation of 77 Alzheimer associations around the world.
ADI is committed to strengthening Alzheimer associa-
tions worldwide, raising awareness regarding dementia
and Alzheimer's Disease and advocating for more and bet-
ter services for people with dementia and their caregivers.
ADI is supported in part by grants from GlaxoSmithKline,
Novartis, Lundbeck, Pfizer and Eisai.
Authors' contributions
MP prepared the first draft with the assistance of JLdR.
Other authors reviewed the manuscript, provided further
contributions and suggestions. All of the authors worked
collectively to develop the algorithms and methods
described in this paper.
Acknowledgements
This study was funded by the Wellcome Trust Health Consequences of 
Population Change Programme (GR066133). Alzheimer's Disease Interna-
tional has provided support for networking and infrastructure.
References
1. American Psychiatric Association: Diagnostic and Statistical manual of
Mental Disorders, edn 3 revised AMA, Washington DC; 1987. 
2. American Psychiatric Association: Diagnostic and Statistical Manual of
Mental Disorders 4th edition. Washington DC, AMA; 1994. 
3. O'Connor DW, Blessed G, Cooper B, Jonker C, Morris JC, Presnell
IB, Ames D, Kay DW, Bickel H, Schaufele M, Wind A, Coats M, Berg
L: Cross-national interrater reliability of dementia diagnosis
in the elderly and factors associated with disagreement.  Neu-
rology 1996, 47:1194-1199.
4. Baldereschi M, Amato MP, Nencini P, Pracucci G, Lippi A, Amaducci
L, Gauthier S, Beatty L, Quiroga P, Klassen G: Cross-national inter-
rater agreement on the clinical diagnostic criteria for
dementia. WHO-PRA Age-Associated Dementia Working
Group, WHO-Program for Research on Aging, Health of
Elderly Program.  Neurology 1994, 44:239-242.
5. Prince M, Acosta D, Chiu H, Scazufca M, Varghese M: Dementia
diagnosis in developing countries: a cross-cultural validation
study.  The Lancet 2003, 361:909-917.
6. Prince M, Ferri CP, Acosta D, Albanese E, Arizaga R, Dewey M,
Gavrilova SI, Guerra M, Huang Y, Jacob KS, Krishnamoorthy ES, McK-
eigue P, Rodrigues JL, Salas A, Sosa AL, Sousa R, Stewart R, Uwakwe
R: The protocols for the 10/66 Dementia Research Group
population-based research programme.  BMC Public Health
2007, 7:165.
7. Hall KS, Hendrie HH, Brittain HM, Norton JA, Rodgers DD, Prince
CS, Pillay N, Blue AW, Kaufert JN, Nath A, Shelton P, Postl BD, Osun-
tokun BO: The development of a dementia screeing interview
in two distinct languages.  International Journal of Methods in Psychi-
atric Research 1993, 3:1-28.
8. Goodglass H, Kaplan E: Assessment of Dysphasia and related disorders
Philadelphia, Lea and Febiger; 1983. 
9. Ganguli M., Chandra V., Gilbey J.: Cognitive test performance in
a community-based non demented elderly sample in rural
India: the Indo-US cross national dementia epidemiology
study.  International Psychogeriatrics 1996, 8:507-524.
10. Copeland JRM, Dewey ME, Griffith-Jones HM: A computerised
psychiatric diagnostic system and case nomenclature for eld-
erly subjects: GMS and AGECAT.  Psychological Medicine 1986,
16:89-99.
11. Prince M, Acosta D, Chiu H, Copeland J, Dewey M, Scazufca M, Var-
ghese M: Effects of education and culture on the validity of the
Geriatric Mental State and its AGECAT algorithm.  Br J Psy-
chiatry 2004, 185:429-436.
12. Dewey ME, Copeland JR: Diagnosis of dementia from the his-
tory and aetiology schedule.  International Journal of Geriatric Psy-
chiatry 2001, 16:912-917.
13. Rehm J, Ustun TB, Saxena S: On the development and psycho-
metric testing of the WHO screening instrument to assess
disablement in the general population.  International Journal of
Methods in Psychiatric Research 2000, 8:110-122.
14. Kaufer DI, Cummings JL, Ketchel P, Smith V, MacMillan A, Shelley T,
Lopez OL, DeKosky ST: Validation of the NPI-Q, a brief clinical
form of the Neuropsychiatric Inventory.  J Neuropsychiatry Clin
Neurosci 2000, 12:233-239.
15. Morris JC: The Clinical Dementia Rating (CDR): current ver-
sion and scoring rules [see comments].  Neurology 1993,
43:2412-2414.
16. Reisberg B, Sartorius N: DIAGNOSTIC CRITERIA IN DEMEN-
TIA. A Comparison of Current Criteria, Research Chal-Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Public Health 2008, 8:219 http://www.biomedcentral.com/1471-2458/8/219
Page 12 of 12
(page number not for citation purposes)
lenges, and Implications for DSM V and ICD 11.  In Diagnostic
Issues in Dementia. Advancing the Research Agenda for DSM V Edited by:
Sunderland T, Jeste DV, Baiyewu O, Sirovatka PJ and Regier D. Arling-
ton, Virginia, American Psychiatric Pub Inc; 2007:27-50. 
17. Cronbach LE, Meehl PE: Construct validity in psychological
tests.  Psychological Bulletin 1955, 52:281-302.
18. Erkinjuntti T, Ostbye T, Steenhuis R, Hachinski V: The effect of dif-
ferent diagnostic criteria on the prevalence of dementia.  N
Engl J Med 1997, 337:1667-1674.
19. Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, Hall
K, Hasegawa K, Hendrie H, Huang Y, Jorm A, Mathers C, Menezes PR,
Rimmer E, Scazufca M: Global prevalence of dementia: a Delphi
consensus study.  Lancet 2006, 366:2112-2117.
20. Wimo A, Winblad B, Aguero-Torres H, vonStrauss E: The Magni-
tude of Dementia Occurrence in the World.  Alzheimer Dis
Assoc Disord 2004, 17(2):63-67.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2458/8/219/pre
pub